Werlinich Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AIM
AAMU
BCAM
JWM
P
SAM
GIA
Werlinich Asset Management's DGX Position: Q2 2026 in Review
Werlinich Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 3,080 shares worth $653K. The position accounts for 0.25% of the portfolio, ranked #52.
Werlinich Asset Management first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.37M in Q4 2021. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Werlinich Asset Management held 3,080 shares of Quest Diagnostics worth $653K as of Q2 2026.
- Werlinich Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.25% of Werlinich Asset Management's portfolio in Q2 2026, its #52 holding.
- Werlinich Asset Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
- Werlinich Asset Management's Quest Diagnostics position peaked at $1.37M in Q4 2021.
- 210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Werlinich Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.